BCG vaccine trial update, with Professor Andreas Diacon

Loading player...
Stellenbosch University Professor Andreas Diacon is the force behind a 500-person clinical trial aimed at determining whether the BCG vaccines many South Africans got as children to protect against TB are indeed a shield against Covid-19. The trial involves revaccination of BCG that’s been universally applied in South Africa since 1973. Numerous reports have pointed out a correlation between infection rates for countries where BCG is universally administered as being far lower than in those countries like the USA, Italy and Belgium where it was never used. Learn more about your ad choices. Visit megaphone.fm/adchoices
13 Jul 2020 6AM English South Africa Investing · Business News

Other recent episodes

To study or to start a business? The choice that built Bubbadue

More than one in 10 university graduates in South Africa cannot find a job. With an economy that creates far too few jobs for the people entering it, and AI starting to eat into white-collar work, many school leavers and their parents are asking whether a degree is still the…
20 Nov 5AM 14 min

BN Edge | Michael Beaumont on ActionSA's coalition hand and the DA standoff

Michael Beaumont has been called the power behind ActionSA's throne, and he's the man running its coalition talks across Gauteng. Speaking to Alec Hogg hours before ActionSA's first sit-down with the DA, he said the DA had never once come to the table until then, and that his party had…
19 Nov 9AM 50 min